The Polish-based startup wanted to raise awareness of funding and plans to open new offices.
We worked with Infermedica to tell the US and pan-European media about its recently closed Series A. Generating $10m, the Polish-based startup wanted to raise awareness of the funding, and its plans to open new offices in the US and Germany and invest in R&D for its cutting edge, AI-driven medical diagnosis and triage consultation platform
As Infermedica is an innovative provider of advanced medical technology, we needed to quickly grasp the expert messaging and transform it into an engaging, media-friendly press release. Following approval from Infermedica and its investors, we then pre-pitched it to key journalists across startup, funding, insurance and healthtech.
Results we’re proud of
Increase in visitors to Infermedica’s site
Increase in online mentions
Approx. readership of coverage secured
All in the details
Through our strong media relations, we secured 32+ pieces of high-quality coverage. This included a TechCrunch interview, as well as dedicated articles on VentureBeat, Fortune, Tech.eu and EU Startups.
Increased online mentions
With an approx. readership of 419m, the coverage resulted in a 203% increase in visitors to Infermedica’s site and a 506% increase in online mentions
“Aspectus did a fantastic job. The announcement day was a wonderful occasion for our company and we received many positive messages of congratulations from all over the world. We simply didn’t expect such a brilliant result.”
Content Marketing Manager, Infermedica
Devising and delivering the launch of major new retail investment challenger brand
Introducing the company to the UK media and developing a compelling brand narrative to raise its profile
Building new links with key identified target media and diversify into wider vertical press
Launch of the SRSS technology, supporting its journey to commercialisation with a funnel-based strategy
Raising the European profile of Clearwater Analytics, using survey research results of institutional investors
Raising the profile of their CEO, Oliver Blower, in the business press